Semaglutide triggers nausea in approximately 25-40% of users during the initial weeks of treatment, primarily through activation of GLP-1 receptors in the chemoreceptor trigger zone of the brain
Your stomach physically cannot accommodate the same volume it could before treatment, and overfilling it triggers nausea, bloating, and discomfort
GHRP-2 is more potent for GH release but also elevates prolactin at higher doses, raising gynecomastia concerns
20222023: Tirzepatide and the SURMOUNT Trials Tirzepatide (Mounjaro) raised the bar
It also slows gastric emptying, meaning food stays in your stomach longer, so you feel satisfied with smaller portions
Clearer Thinking If your thoughts have felt scrambled or your memory is slipping, cognitive clarity is often one of the most celebrated benefits